Brief: Dancann Pharma A/S Announces The Appointment Of Louise Conradsen As New CEO
12/04/2022 16:43
April 12 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* ANNOUNCES THE APPOINTMENT OF LOUISE CONRADSEN AS NEW CHIEF
EXECUTIVE OFFICER TO ACCELERATE GROWTH OF CANNGROS APS
* LOUISE CONRADSEN WILL START IN HER NEW FUNCTION WITH
EFFECT FROM
10TH MAY 2022
Source text for Eikon: ID:nWkr56f138
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874